PSI Sci
New here? Follow the money and the votes · Not sure of your district? Find your U.S. House member · Find your state legislators

H.R. 1014: HEART for Women Act

Before you vote › Federal bills

H.R. 1014: HEART for Women Act

110th Congress · introduced 2007-02-13 · Health · Latest: Received in the Senate.

federal

Follow this bill, step by step

  1. Where it came from: introduced 2007-02-13 · official record
  2. Who proposed it: Rep. Capps, Lois [D-CA-23] · what a sponsor is
  3. What happened next: 1 recorded vote in our records. Latest: House roll call 642 (2008): On Motion to Suspend the Rules and Pass, as Amended, HR1014 (2008-09-25), Passed. See all
  4. Where it stands now: Received in the Senate. Not final yet: this can still change. We check for updates every day.
  5. If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

HEART for Women Act

Plain summary

Heart Disease Education, Analysis Research, and Treatment for Women Act or the HEART for Women Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary of Health and Human Services to deny a new drug application if the application fails to include required information on clinical investigations. Directs the Secretary to require that a new drug application include any clinical data possessed by the applicant that relates to the safety and effectiveness of the drug involved by gender, age, and racial subgroup. (Currently, this is required by regulation.) Requires the Secretary to develop guidance for the staff of the Food and Drug Administration (FDA) to ensure that new drug applications are adequately reviewed to determine whether they include the required clinical data. Authorizes the Secretary to place a clinical hold on an investigation under an investigational new drug application if the sponsor of the investigation fails to meet the requirements of an annual report on the status of each study in progress. Applies provisions relating to clinical data submission for new drug applications to an investigational new drug application, an application for a biologics license for a biological product, an application for premarket approval for a class III device, and an application for investigational use of a device. (Sec. 3) Amends the Public Health Service Act to require the Secretary to provide that all nonidentifiable patient safety work product reported to and among the network of patient safety databases be identified by sex. Directs that analyses of national and regional statistics of information reported to and among the network of patient safety databases take into account data that specifically relates to women and any disparities between treatment and the quality of care between males and females. (Sec. 4) Requires the Director of the Agency for Healthcare Research and Quality to conduct and support research and support demonstrations to identify and evaluate clinical and organizational strategies to improve the quality of and access to care for women with heart disease, stroke, and other cardiovascular diseases. (Sec. 5) Requires the Secretary to develop and distribute to females who are age 65 or older, physicians, and other appropriate health care professionals educational materials relating to the prevention diagnosis and treatment of heart disease, stroke, and cardiovascular diseases in women. Requires the Secretary, acting through the Bureau of Health Professions of the Health Resources and Services Administration, to conduct an education and awareness campaign for physicians and other health care professionals relating to the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. (Sec. 6) Expands the grant program authorizing the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to award grants for preventive health services to all states. (Currently, only three grants may be awarded). Authorizes appropriations for FY2009-FY2013.

Congressional Research Service summary (Passed House amended), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

HEART for Women Act

Source: Congressional Research Service summary (Passed House amended)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Capps, Lois [D-CA-23] · 238 cosponsors

Cost estimate: CBO cost estimate: H.R. 1014, Heart Disease Education, Analysis Research, and Treatment for Women Act (2008-10-09); CBO cost estimate: H.R. 1014, Heart Disease Education, Analysis Research, and Treatment for Women Act (2008-10-09)

Cosponsors on this site

Betty McCollum (D-MN), Mazie K. Hirono (D-HI), Janice D. Schakowsky (D-IL), Shelley Moore Capito (R-WV), Eleanor Holmes Norton (D-DC), Al Green (D-TX), Stephen F. Lynch (D-MA), Chris Van Hollen (D-MD), Zoe Lofgren (D-CA), Linda T. Sánchez (D-CA), Steve Cohen (D-TN) and 178 more.

Recorded votes

Words on this page, explained (2)
Appropriation
Money a legislature sets aside by law for a specific purpose. Government agencies may spend public money only as it has been appropriated.
Rulemaking
The process agencies use to write regulations that carry out laws passed by Congress or a legislature. Usually an agency publishes a proposed rule, takes public comments, then publishes a final rule.

Plain meanings written from linked sources. All words.

Sources

Record fed-us-cong110-hr1014 · catalog fed-us-congress-bills-cong110 · updated 2026-11-15 by psicol fed-bills-cong110